StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.52+0.02 (+0.57%)

Close on Nov 20, 2026Market cap $45.23MP/E –Yield –

Clene gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Clene's gross profit for the twelve months ending Jun 30, 2026 was $138.00K, down 40.0% year over year. For fiscal 2025 it was $157.00K, down 42.3% from the year before. The highest annual figure on record is $533.00K in fiscal 2023.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$157.00K-42.3%
FY2024Dec 31, 2024$272.00K-49.0%
FY2023Dec 31, 2023$533.00K+19.2%
FY2022Dec 31, 2022$447.00K+3.0%
FY2021Dec 31, 2021$434.00K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$54.00K+100.0%
Q1 FY2026Mar 31, 2026$15.00K-75.4%
Q4 FY2025Dec 31, 2025$54.00K-26.0%
Q3 FY2025Sep 30, 2025$15.00K-78.3%
Q2 FY2025Jun 30, 2025$27.00K-63.0%
Q1 FY2025Mar 31, 2025$61.00K+7.0%
Q4 FY2024Dec 31, 2024$73.00K-44.7%
Q3 FY2024Sep 30, 2024$69.00K-28.1%
Q2 FY2024Jun 30, 2024$73.00K-64.0%
Q1 FY2024Mar 31, 2024$57.00K-44.1%
Q4 FY2023Dec 31, 2023$132.00K+277.1%
Q3 FY2023Sep 30, 2023$96.00K+220.0%
Q2 FY2023Jun 30, 2023$203.00K+111.5%
Q1 FY2023Mar 31, 2023$102.00K–
Q2 FY2022Jun 30, 2022$35.00K-64.3%
Q1 FY2022Mar 31, 2022$30.00K–
Q3 FY2021Sep 30, 2021$96.00K–
Q2 FY2021Jun 30, 2021-$354.00K–
Q3 FY2020Sep 30, 2020$98.00K–

More Clene figures

See a number that looks wrong?